CoChat
Cited by 230

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Community-wide Screening for Tuberculosis in a High-Prevalence Setting

Marks, Guy B., Nguyen, Nhung V., Nguyen, Phuong T.B., Nguyen, Thu-Anh, Nguyen, Hoa B., Tran, Khoa H., Nguyen, Son V., Luu, Khanh B., Tran, Duc T.T., Vo, Qui T.N., Le, Oanh T.T., Nguyen, Yen H., Do, Vu Q., Mason, Paul H., Nguyen, Van-Anh T., Ho, Jennifer, Sintchenko, Vitali, Nguyen, Linh N., Britton, Warwick J., Fox, Greg J. · 2019 · New England Journal of Medicine

Abstract

BACKGROUND: The World Health Organization has set ambitious targets for the global elimination of tuberculosis. However, these targets will not be achieved at the current rate of progress. METHODS: We performed a cluster-randomized, controlled trial in Ca Mau Province, Vietnam, to evaluate the effectiveness of active community-wide screening, as compared with standard passive case detection alone, for reducing the prevalence of tuberculosis. Persons 15 years of age or older who resided in 60 intervention clusters (subcommunes) were screened for pulmonary tuberculosis, regardless of symptoms, annually for 3 years, beginning in 2014, by means of rapid nucleic acid amplification testing of spontaneously expectorated sputum samples. Active screening was not performed in the 60 control clusters in the first 3 years. The primary outcome, measured in the fourth year, was the prevalence of microbiologically confirmed pulmonary tuberculosis among persons 15 years of age or older. The secondary outcome was the prevalence of tuberculosis infection, as assessed by an interferon gamma release assay in the fourth year, among children born in 2012. RESULTS: (prevalence ratio, 0.56; 95% confidence interval [CI], 0.40 to 0.78; P<0.001). The prevalence of tuberculosis infection in children born in 2012 was 3.3% in the intervention group and 2.6% in the control group (prevalence ratio, 1.29; 95% CI, 0.70 to 2.36; P = 0.42). CONCLUSIONS: Three years of community-wide screening in persons 15 years of age or older who resided in Ca Mau Province, Vietnam, resulted in a lower prevalence of pulmonary tuberculosis in the fourth year than standard passive case detection alone. (Funded by the Australian National Health and Medical Research Council; ACT3 Australian New Zealand Clinical Trials Registry number, ACTRN12614000372684.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1902129

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. 10.2471/BLT.09.067801 · DOI · Paper page
  2. 10.1016/S0140-6736(10)60483-7 · DOI · Paper page
  3. 10.1186/1472-6963-10-10 · doi:10.1186/1472-6963-10-10
  4. 10.1016/j.amjmed.2006.10.025 · DOI
  5. 10.1371/journal.pone.0005602 · doi:10.1371/journal.pone.0005602
  6. 10.1016/S0168-8510(01)00143-9 · DOI · Paper page
  7. 10.1016/j.socscimed.2009.03.041 · DOI · Paper page
  8. 10.1016/S2214-109X(16)30199-1 · DOI · Paper page
  9. 10.1016/S0140-6736(18)32389-4 · DOI · Paper page
  10. 10.1016/S0140-6736(10)61503-6 · DOI
  11. 10.1016/S0041-3879(64)80081-7 · doi:10.1016/s0041-3879(64)80081-7
  12. 10.1016/S0041-3879(64)80016-7 · doi:10.1016/s0041-3879(64)80016-7
  13. Golub JE, Mohan CI, Comstock GW, Chaisson RE. Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 2005;9:1183-1203.16333924
  14. 10.1183/13993003.01449-2016 · doi:10.1183/13993003.01449-2016
  15. Comstock GW, Ferebee SH, Hammes LM. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 1967;95:935-943.6026165
  16. 10.1056/NEJMoa1700209 · DOI · Paper page
  17. 10.1016/S0140-6736(03)15332-9 · DOI · Paper page
  18. 10.1164/rccm.201310-1846OC · DOI
  19. 10.1016/S0140-6736(11)60438-8 · DOI · Paper page
  20. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London: Arnold, 2000.
  21. 10.1016/S0140-6736(10)61425-0 · DOI · Paper page
  22. 10.1016/S0140-6736(13)61131-9 · DOI · Paper page
  23. 10.2471/BLT.13.131581 · DOI
  24. Tupasi TE, Radhakrishna S, Chua JA, et al. Significant decline in the tuberculosis burden in the Philippines ten years after initiating DOTS. Int J Tuberc Lung Dis 2009;13:1224-1230.19793426
  25. Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998;2:27-36.9562108
  26. 10.1016/S0140-6736(13)62639-2 · DOI · Paper page
  27. 10.1016/S1473-3099(16)30067-6 · doi:10.1016/s1473-3099(16)30067-6
  28. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014;1:CD009593-CD009593.24448973
  29. 10.5588/ijtld.16.0846 · doi:10.5588/ijtld.16.0846
  30. 10.1186/s12879-019-3778-9 · DOI
  31. 10.1093/infdis/jix362 · DOI · Paper page
  32. 10.1371/journal.pone.0151073 · DOI
  33. 10.1371/journal.pone.0105628 · DOI
  34. Comstock GW. Isoniazid prophylaxis in an undeveloped area. Am Rev Respir Dis 1962;86:810-822.14022524

Cited by

See all 230

Metadata

Authors
Marks, G. B., Nguyen, N. V., Nguyen, P. T. B., Nguyen, T.-A., Nguyen, H. B., Tran, K. H., Nguyen, S. V., Luu, K. B., Tran, D. T. T., Vo, Q. T. N., Le, O. T. T., Nguyen, Y. H., Do, V. Q., Mason, P. H., Nguyen, V.-A. T., Ho, J., Sintchenko, V., Nguyen, L. N., Britton, W. J., & Fox, G. J.
Venue
New England Journal of Medicine
Published
2019-10-03
Volume
381
Issue
14
Pages
1347-1357
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2979246892
Cited by
230
References
2
FWCI
14.93
Type
journal article
Language
en
Open access
closed
Funders
National Health and Medical Research Council (App 1045236)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.